Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-α

FEBS Letters

Volumn 583, Issue 9, 2009, Pages 1434-1438

  Ikeda, Masanori ^a   Mori, Kyoko ^a   Ariumi, Yasuo ^a   Dansako, Hiromichi ^a   Kato, Nobuyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Interferon; Oncostatin M

Indexed keywords

ALPHA INTERFERON; CYTOKINE; ONCOSTATIN M;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MENTAL CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA REPLICATION;

ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HEPACIVIRUS; INTERFERON-ALPHA; ONCOSTATIN M; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 67349148106     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.03.054     Document Type: Article

References (19)

1. Fried M.W., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New Engl. J. Med. 347 (2002) 975-982
2. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
3. Rose T.M., and Bruce A.G. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. USA 88 (1991) 8641-8645
4. Zarling J.M., Shoyab M., Marquardt H., Hanson M.B., Lioubin M.N., and Todaro G.J. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83 (1986) 9739-9743
5. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L.S., and Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271 (1996) 32635-32643
6. Dillon S.R., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5 (2004) 752-760
7. Hamada T., et al. Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am. J. Pathol. 171 (2007) 872-881
8. Kinoshita T., Sekiguchi T., Xu M.J., Ito Y., Kamiya A., Tsuji K., Nakahata T., and Miyajima A. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc. Natl. Acad. Sci. USA 96 (1999) 7265-7270
9. Ikeda M., Abe K., Dansako H., Nakamura T., Naka K., and Kato N. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem. Biophys. Res. Commun. 329 (2005) 1350-1359
10. Ikeda M., Abe K., Yamada M., Dansako H., Naka K., and Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44 (2006) 117-125
11. Abe K., Ikeda M., Dansako H., Naka K., and Kato N. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Virus Res. 125 (2007) 88-97
12. Kato N., Ikeda M., Mizutani T., Sugiyama K., Noguchi M., Hirohashi S., and Shimotohno K. Replication of hepatitis C virus in cultured non-neoplastic human hepatocyte. Jpn. J. Cancer Res. 87 (1996) 787-792
13. Naka K., Ikeda M., Abe K., Dansako H., and Kato N. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha. Biochem. Biophys. Res. Commun. 330 (2005) 871-879
14. Dansako H., Naganuma A., Nakamura T., Ikeda F., Nozaki A., and Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res. 97 (2003) 17-30
15. Kato N., et al. Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem. Biophys. Res. Commun. 306 (2003) 756-766
16. Suhnel J. Evaluation of synergism or antagonism for the combined action of antiviral agents. Antiviral Res. 13 (1990) 23-39
17. Mahboubi K., and Pober J.S. Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M. J. Biol. Chem. 277 (2002) 8012-8021
18. Znoyko I., Sohara N., Spicer S.S., Trojanowska M., and Reuben A. Expression of oncostatin M and its receptors in normal and cirrhotic human liver. J. Hepatol. 43 (2005) 893-900
19. Yano M., Ikeda M., Abe K., Dansako H., Ohkoshi S., Aoyagi Y., and Kato N. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob. Agents Chemother. 51 (2007) 2016-2027